Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Henan Lingrui Pharmaceutical Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥276 Mil. Henan Lingrui Pharmaceutical Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-1 Mil.
Henan Lingrui Pharmaceutical Co's interest coverage for the quarter that ended in Mar. 2026 was 361.11.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Henan Lingrui Pharmaceutical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Henan Lingrui Pharmaceutical Co's Interest Coverage or its related term are showing as below:
SHSE:600285'
s Interest Coverage Range Over the Past 10 Years
Min: 14.97 Med: 125.3 Max: 554.34
Current: 209.7
SHSE:600285's Interest Coverage is ranked better than 85.88% of 687
companies
in the Drug Manufacturers industry
Industry Median: 12.75
vs SHSE:600285: 209.70
Henan Lingrui Pharmaceutical Co (SHSE:600285) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Henan Lingrui Pharmaceutical Co Interest Coverage Related Terms
Henan Lingrui Pharmaceutical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Henan Lingrui Pharmaceutical Co Interest Coverage Chart
SHSE:600285 vs ZTS, UTHR: Interest Coverage Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Henan Lingrui Pharmaceutical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Henan Lingrui Pharmaceutical Co Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Henan Lingrui Pharmaceutical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Henan Lingrui Pharmaceutical Co's Interest Coverage falls into.
Henan Lingrui Pharmaceutical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Interest Coverage of 361.11 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. This is 188% above median its historical median of 125.30. Over the past decade, Henan Lingrui Pharmaceutical Co's Interest Coverage has ranged from 14.97 to 554.34. According to the industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #97 out of 687 companies in the Drug Manufacturers industry, placing it in the top 14.1%.
Is Henan Lingrui Pharmaceutical Co's Interest Coverage too high?
Henan Lingrui Pharmaceutical Co's current Interest Coverage of 361.11 is 188% above median its 10-year median of 125.30. Over the past 10 years, this metric has ranged from a low of 14.97 to a high of 554.34. The Drug Manufacturers industry median Interest Coverage is 12.75. Henan Lingrui Pharmaceutical Co's value of 361.11 is 2732.2% above this industry median. Based on the distribution chart, Henan Lingrui Pharmaceutical Co ranks #97 out of 687 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Interest Coverage compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Henan Lingrui Pharmaceutical Co ranks #97 out of 687 companies for Interest Coverage. This places Henan Lingrui Pharmaceutical Co in the top 14% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 12.75. Henan Lingrui Pharmaceutical Co's value of 361.11 is 2732.2% above this benchmark. Historically, Henan Lingrui Pharmaceutical Co's own Interest Coverage has ranged from 14.97 to 554.34 over the past decade. While the company's 10-year median is 125.30 vs. the industry median of 12.75, Henan Lingrui Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.75, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Henan Lingrui Pharmaceutical Co's current Interest Coverage of 361.11 is 2732.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Henan Lingrui Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Henan Lingrui Pharmaceutical Co's current Interest Coverage is 361.11, which is 188% above median its own 10-year median of 125.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.66 — trading 7.1% below its estimated fair value. The current Interest Coverage is 361.11, which is 188% above median its 10-year median of 125.30 and 2732.2% above the Drug Manufacturers industry median of 12.75. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Interest Coverage is 361.11 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥22.66 is trading 7.1% below its estimated GF Value™ of ¥24.39.
GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.
Key valuation signals for SHSE:600285:
Interest Coverage: 361.11 (188% above median its 10-year median of 125.30)
GF Value™: ¥24.39 vs. price of ¥22.66 (7.1% below fair value)
Industry Position: 2732.2% above the Drug Manufacturers median (#97 of 687)
No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Henan Lingrui Pharmaceutical Co Business Description
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score
Get the complete analysis for SHSE:600285
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600285 has been successfully added to your 
